Zhao, Jingwei
Zhang, Yunxian
Fan, Mingxing
Han, Xiaoguang
Liu, Bo
He, Da
Tian, Wei
Funding for this research was provided by:
Beijing Natural Science Foundation (L202005, L202005, L202005)
Capital's Funds for Health Improvement and Research (2020-2-2072, 2020-2-2072)
the CAMS Innovation Fund for Medical Sciences (2021-I2M-5-007, 2021-I2M-5-007, 2021-I2M-5-007, 2021-I2M-5-007, 2021-I2M-5-007, 2021-I2M-5-007)
Nova Program of Beijing Jishuitan Hospital (XKXX202210)
Article History
Received: 5 April 2023
Accepted: 27 July 2023
First Online: 5 January 2024
Declarations
:
: The study was approved by the Ethics Committee of Beijing Jishuitan Hospital. The approval number is “202101-01”. According to the ethical review approval, the study adheres to the ethical principles of the Declaration of Helsinki, the International Ethical Guidelines for Biomedical Research Involving Human Subjects (CIOMS, 2002), the Ethical Administrative Procedures on Biomedical Research Involving Human Subjects (National Health Commission of the People’s Republic of China, 2016), and the Good Clinical Practice Guidelines (National Medical Products Administration, 2003). Written consents from the participates were waived due to the retrospective design of the study. However, their personal information were anonymized before analysis. (No Internal Review Board, except for the Ethics Committee, has been set up for ethical review purposes in our hospital.)
: No competing interest exits in the manuscript.